Name
Abu Salim Mustafa
Email
abusalim
@HSC.EDU.KW
Title
Professor
Faculty
Faculty of Medicine
Department
Microbiology
Office
FOM Building - 5th Floor - Room 534
Phone
36505
<P>Telephone no.: Office: 24636505 Mobile: 66529609</P> <P>Fax: 25332719</P> <P>Field of Specialization: Molecular Microbiology and Immunology</P> <P>Research Interests: <SPAN style="FONT-SIZE: 12pt; LAYOUT-GRID-MODE: line">Molecular biology and immunology of infectious diseases with specific reference to diagnosis and identification of vaccine candidates against tuberculosis and other mycobacterial diseases<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P>Publications (for the last 5 years):</P><SPAN style='FONT-FAMILY: "Garamond","serif"; mso-bidi-language: AR-KW'> <P class=desc2 style="BACKGROUND: white; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style="FONT-SIZE: 10pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">1.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN style="FONT-SIZE: 10pt"><FONT face="Times New Roman">Siddique I, Al-Qabandi A, Al-Ali J, Alazmi W, Memon A, <B>Mustafa AS</B>, Junaid TA (2014). Association between Helicobacter pylori genotypes and severity of chronic gastritis, peptic ulcer disease and gastric mucosal interleukin-8 levels: Evidence from a study in the Middle East. <SPAN class=jrnl>Gut Pathog</SPAN>en<SPAN style="mso-spacerun: yes"> </SPAN>26;6:41.<o:p></o:p></FONT></SPAN></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-AUTOSPACE: ; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-layout-grid-align: none"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">2.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT></SPAN></B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2> (2014). T-helper 1, T-helper 2, pro-inflammatory and anti-inflammatory cytokines in tuberculosis. <o:p></o:p></FONT></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in"><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2><FONT face="Times New Roman">International Journal of Pharma Medicine and Biological Sciences 3, 1-14.<o:p></o:p></FONT></FONT></SPAN></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">3.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT></SPAN></B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2> (2014). Characterization of a cross-reactive, immunodominant and HLA-promiscuous epitope of</FONT> <I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2>-specific major antigenic protein PPE68.</FONT> </SPAN><SPAN class=jrnl><FONT size=2>PLoS One</FONT></SPAN><FONT size=2> 9(8):e103679.<SPAN style='mso-bidi-font-family: "Times New Roman"'><o:p></o:p></SPAN></FONT></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">4.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT face="Times New Roman"><FONT size=2>Amoudy HA, Ebrahimi BH,</FONT> <B><FONT size=2>Mustafa AS</FONT> </B><FONT size=2>(2014). Immune responses against</FONT> <I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2>-specific proteins PE35 and CFP10 in mice immunized with recombinant</FONT> <I><FONT size=2>Mycobacterium vaccae</FONT></I><FONT size=2>.</FONT> <SPAN class=jrnl><FONT size=2>Saudi Med J</FONT></SPAN><FONT size=2> 35:350-359.<o:p></o:p></FONT></FONT></SPAN></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='LAYOUT-GRID-MODE: line; mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">5.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT></SPAN></B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2> (2014).</FONT> <SPAN style="LAYOUT-GRID-MODE: line"><FONT size=2>The future of</FONT><SPAN style="mso-spacerun: yes"><FONT size=2> </FONT></SPAN><I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2>-specific antigens/peptides in tuberculin skin testing for the diagnosis of tuberculosis. J Mycobac Dis 4:3.<o:p></o:p></FONT></SPAN></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='LAYOUT-GRID-MODE: line; mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">6.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN style='COLOR: black; mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT></SPAN></B><SPAN style='COLOR: black; mso-bidi-font-family: "Times New Roman"'><FONT size=2> (2013).</FONT> </SPAN><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Diagnostic and Vaccine Potentials of ESAT-6 Family Proteins encoded</FONT><SPAN style="mso-spacerun: yes"><FONT size=2> </FONT></SPAN><FONT size=2>by</FONT> <I><FONT size=2>M. tuberculosis</FONT></I><FONT size=2> genomic regions absent in</FONT> <I><FONT size=2>M. bovis</FONT></I><FONT size=2> BCG.</FONT> <SPAN style="LAYOUT-GRID-MODE: line"><FONT size=2>J Mycobac Dis</FONT> </SPAN><FONT size=2>3:129.<SPAN style="LAYOUT-GRID-MODE: line"><o:p></o:p></SPAN></FONT></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: justify; MARGIN: 0in 1.45pt 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; tab-stops: right -292.5pt"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">7.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT></SPAN></B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2> (2013).</FONT> <SPAN style="COLOR: black"><FONT size=2>In silico analysis and experimental validation of</FONT><SPAN style="mso-spacerun: yes"><FONT size=2> </FONT></SPAN><I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2>-specific proteins and peptides of</FONT> <I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2> for immunological diagnosis and vaccine development.</FONT><SPAN style="mso-spacerun: yes"><FONT size=2> </FONT></SPAN></SPAN><FONT size=2>Medical Principles and Practice 22 (Suppl 1): 43-51.<o:p></o:p></FONT></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: justify; MARGIN: 0in 1.45pt 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; tab-stops: right -297.0pt"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">8.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><SPAN style='COLOR: black; mso-bidi-font-family: "Times New Roman"'><FONT size=2>Shaban K, Amoudy HA,</FONT> <B><FONT size=2>Mustafa AS</FONT></B><FONT size=2> (2013). Cellular immune responses to recombinant</FONT> <I><FONT size=2>Mycobacterium bovis</FONT></I><FONT size=2> BCG constructs expressing major antigens of region of difference 1 of</FONT><SPAN style="mso-spacerun: yes"><FONT size=2> </FONT></SPAN><I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2>. Clinical Vaccine Immunology</FONT> </SPAN><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>20:1230-1237.<o:p></o:p></FONT></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">9.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT face="Times New Roman"><FONT size=2>Albert MJ,</FONT> <B><FONT size=2>Mustafa AS</FONT></B><FONT size=2>, Islam A, Haridas S (2013) Oral immunization with cholera toxin provides protection against</FONT> <I><FONT size=2>Campylobacter jejuni</FONT></I><FONT size=2> in an adult mouse intestinal colonization model. MBio 4. pii: e00246-13.<o:p></o:p></FONT></FONT></SPAN></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">10.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT></SPAN></B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2> (2012). What's New in the Development of Tuberculosis Vaccines.</FONT> <B style="mso-bidi-font-weight: normal"><FONT size=2>Medical Principles and Practice</FONT></B><SPAN style="mso-bidi-font-weight: bold"><FONT size=2> </FONT></SPAN><FONT size=2>21:195-196.<o:p></o:p></FONT></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">11.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT> </SPAN></B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>(2012).</FONT> <SPAN style="COLOR: black"><FONT size=2>Proteins and peptides encoded by</FONT> <I><FONT size=2>M. tuberculosis</FONT></I><FONT size=2>-specific genomic regions for immunological diagnosis of tuberculosis.</FONT><B><FONT size=2> Journal of</FONT> </B></SPAN></SPAN><B><SPAN style='mso-fareast-font-family: Calibri; mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mycobacterial Diseases</FONT> </SPAN></B><SPAN style='mso-fareast-font-family: Calibri; mso-bidi-font-family: "Times New Roman"'><FONT size=2>2:e114.<o:p></o:p></FONT></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">12.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT face="Times New Roman"><FONT size=2>Al-Attiyah R, El-Shazly A,</FONT> <B><FONT size=2>Mustafa AS</FONT> </B><FONT size=2>(2012). Comparative analysis of spontaneous and mycobacterial antigen-induced secretion of Th1, Th2 and pro-inflammatory cytokines by peripheral blood mononuclear cells of tuberculosis patients.</FONT> <B><SPAN style="COLOR: black"><FONT size=2>Scandinavian Journal of Immunology</FONT></SPAN></B><FONT size=2> 75:623-632.<o:p></o:p></FONT></FONT></SPAN></P> <P class=MsoListParagraphCxSpFirst style="TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-add-space: auto; tab-stops: -9.0pt -4.5pt"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">13.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt"><FONT face="Times New Roman">Babiker FA, Hoteit LJ, Joseph S, <B>Mustafa AS</B>, a<SUP> </SUP>Juggi<SUP> </SUP>JS (2012). The role of 17-beta estradiol in ischemic preconditioning protection of the heart.<SPAN style="mso-spacerun: yes"> </SPAN><B>Experimental and Clinical Cardiology</B> 17:95-100.<SPAN style="COLOR: black; mso-font-kerning: 18.0pt"><o:p></o:p></SPAN></FONT></SPAN></P> <P class=MsoListParagraphCxSpMiddle style="TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-add-space: auto; tab-stops: -9.0pt -4.5pt"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">14.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-bidi-font-weight: bold">Hanif SNM, Al-Attiyah R, </SPAN><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black">Mustafa AS</SPAN></B><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-bidi-font-weight: bold"> (2011). </SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-fareast-font-family: Calibri">The natural expression of genes encoding major a</SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US">ntigens of Rd1 and Rd9 in </SPAN><I><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-fareast-font-family: Calibri">M. t</SPAN></I><I><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US">uberculosis</SPAN></I><I><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-fareast-font-family: Calibri"> </SPAN></I><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-fareast-font-family: Calibri">and other mycobacteria. <B>Mycobacterial Diseases</B> 1:105. </SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><o:p></o:p></SPAN></FONT></P> <P class=MsoListParagraphCxSpMiddle style="TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-add-space: auto; tab-stops: -9.0pt -4.5pt"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">15.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt"><FONT face="Times New Roman">Hanif SN, Al-Attiyah R, <B>Mustafa AS </B>(2011).<STRONG> </STRONG>Cellular immune responses in mice induced by M. tuberculosis PE35-DNA vaccine construct. <SPAN style="COLOR: black"><B>Scandinavian Journal of Immunology</B><SPAN class=src1> </SPAN></SPAN>74:554-60.<SPAN style="COLOR: black; mso-font-kerning: 18.0pt"><o:p></o:p></SPAN></FONT></SPAN></P> <P class=MsoListParagraphCxSpMiddle style="TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-add-space: auto; tab-stops: -9.0pt -4.5pt"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">16.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN lang=EN-GB style="FONT-SIZE: 10pt">Mustafa AS</SPAN></B><SPAN lang=EN-GB style="FONT-SIZE: 10pt"> (2011). <SPAN class=messageheaderlabel>Comparative evaluation of MPT83 </SPAN>(Rv2873) for <SPAN class=messageheaderlabel>T helper-1 cell reactivity and identification of HLA-promiscuous </SPAN>peptides: studies in <SPAN class=messageheaderlabel><I>M.</I></SPAN> <I>bovis</I> BCG-vaccinated healthy subjects. <B>Clinical and Vaccine Immunology</B> 18:1752-9.<SPAN style="COLOR: black; mso-font-kerning: 18.0pt"><o:p></o:p></SPAN></SPAN></FONT></P> <P class=MsoListParagraphCxSpMiddle style="TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-add-space: auto; tab-stops: -9.0pt -4.5pt"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">17.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt"><FONT face="Times New Roman">Juggi JS, Hoteit LJ, Babiker FA, Joseph H and <B>Mustafa AS</B> (2011). Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumor necrosis factor-alpha-induced damage. <B>Experimental and Clinical Cardiology</B> 16: e5-e10.<SPAN style="COLOR: black; mso-font-kerning: 18.0pt"><o:p></o:p></SPAN></FONT></SPAN></P> <P class=MsoListParagraphCxSpMiddle style="TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-add-space: auto; tab-stops: -9.0pt -4.5pt"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">18.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-bidi-language: AR-KW">Mustafa AS, </SPAN></B><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-bidi-language: AR-KW">Al-Saidi F, El-Shamy ASM and Al-Attiyah R (2011).<B> </B></SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt">Cytokines in response to proteins predicted in genomic regions of difference of <I>Mycobacterium tuberculosis</I>. <B>Microbiology and Immunology</B>, 55:267-278. <SPAN style="COLOR: black; mso-font-kerning: 18.0pt"><o:p></o:p></SPAN></SPAN></FONT></P> <P class=MsoListParagraphCxSpMiddle style="TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-add-space: auto; tab-stops: -9.0pt -4.5pt"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">19.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><SPAN lang=EN-GB style="FONT-SIZE: 10pt; mso-bidi-language: AR-KW">Al-Khodari NY, Al-Attiyah R, and <B>Mustafa AS</B> (2011). </SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt">Identification, diagnostic potential and natural expression of immunodominant seroreactive peptides encoded by five <I>Mycobacterium tuberculosis</I>-specific genomic regions. <B>Clinical and Vaccine Immunology</B> 18:477-482.<SPAN style="COLOR: black; mso-font-kerning: 18.0pt"><o:p></o:p></SPAN></SPAN></FONT></P> <P class=MsoListParagraphCxSpLast style="TEXT-ALIGN: justify; MARGIN: 0in 0in 10pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1; mso-add-space: auto; tab-stops: -9.0pt -4.5pt"><SPAN class=src1><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black; mso-font-kerning: 18.0pt"><SPAN style="mso-list: Ignore"><FONT face="Times New Roman">20.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN lang=EN-GB style="FONT-SIZE: 10pt; COLOR: black"><FONT face="Times New Roman">Hanif SNM, Al-Attiyah R and <B>Mustafa AS</B> (2010). DNA vaccine constructs expressing <I style="mso-bidi-font-style: normal">Mycobacterium tuberculosis</I>-specific genes induce immune responses. <B>Scandinavian Journal of Immunology</B><SPAN class=src1> 72:408-415.<SPAN style="mso-font-kerning: 18.0pt"><o:p></o:p></SPAN></SPAN></FONT></SPAN></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">21.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT></SPAN></B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2> (2010). In silico binding predictions for identification of HLA-DR-promiscuous regions and epitopes of Mycobacterium tuberculosis protein MPT64 (Rv1980c), and their recognition by human Th1 cells</FONT><B><SPAN style="COLOR: black"><FONT size=2>.</FONT><SPAN style="mso-spacerun: yes"><FONT size=2> </FONT></SPAN></SPAN></B><B style="mso-bidi-font-weight: normal"><FONT size=2>Medical Principles and Practice</FONT></B><SPAN style="mso-bidi-font-weight: bold"><FONT size=2> </FONT></SPAN><SPAN class=src1><FONT size=2>19:367-372</FONT></SPAN><SPAN style="mso-bidi-font-weight: bold"><FONT size=2>.<o:p></o:p></FONT></SPAN></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">22.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT face="Times New Roman"><FONT size=2>Al-Attiyah R,</FONT> <B><FONT size=2>Mustafa AS</FONT></B><FONT size=2> (2010). Characterization of human cellular immune responses to</FONT> <I><FONT size=2>Mycobacterium tuberculosis</FONT> </I><FONT size=2>proteins encoded by genes predicted in RD15 genomic region that is absent in</FONT> <I><FONT size=2>Mycobacterium bovis</FONT></I><FONT size=2> BCG.</FONT> <B><FONT size=2>FEMS Immunology and Medical Microbiology</FONT></B><FONT size=2> 59:177-187.<o:p></o:p></FONT></FONT></SPAN></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">23.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT face="Times New Roman"><FONT size=2>Hanif SNM, Al-Attiyah R and</FONT> <B><FONT size=2>Mustafa AS</FONT></B><FONT size=2> (2010).</FONT><B><FONT size=2> </FONT></B><FONT size=2>Molecular cloning, expression, purification and immunological characterization of three low molecular weight proteins encoded by genes in genomic regions of difference of</FONT> <I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2>.</FONT> <B><FONT size=2>Scandinavian Journal of Immunology</FONT></B><FONT size=2> </FONT><SPAN class=src1><FONT size=2>71:353-361</FONT></SPAN><FONT size=2>.<o:p></o:p></FONT></FONT></SPAN></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: left; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">24.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><SPAN style='COLOR: black; mso-bidi-font-family: "Times New Roman"'><FONT size=2>Hanif SNM, Al-Attiyah R and</FONT><B><FONT size=2> </FONT></B></SPAN><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT> </SPAN></B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>(2010). Species-specific antigenic</FONT> <I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2> proteins as tested by delayed-type hypersensitivity response.</FONT> <B><FONT size=2>International Journal of Tuberculosis and Lung Diseases</FONT></B><FONT size=2> </FONT><SPAN class=src1><FONT size=2>14:489-494</FONT></SPAN><FONT size=2>.<o:p></o:p></FONT></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><SPAN style='mso-bidi-font-family: "Times New Roman"'><SPAN style="mso-list: Ignore"><FONT size=2 face="Times New Roman">25.</FONT><SPAN style='FONT: 7pt "Times New Roman"'> </SPAN></SPAN></SPAN><SPAN dir=ltr></SPAN><FONT face="Times New Roman"><SPAN class=messageheaderlabel><B><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Mustafa AS</FONT></SPAN></B></SPAN><SPAN class=messageheaderlabel><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2> (2010).</FONT> </SPAN></SPAN><SPAN style='mso-bidi-font-family: "Times New Roman"'><FONT size=2>Cell mediated immunity assays identify proteins of diagnostic and vaccine potential from genomic regions of difference of</FONT> <I><FONT size=2>Mycobacterium tuberculosis</FONT></I><FONT size=2>.</FONT> <B><FONT size=2>Kuwait Medical Journal</FONT></B><FONT size=2> 42:98-105.</FONT></SPAN></FONT></P> <P class=MsoNormal style="unicode-bidi: embed; DIRECTION: ltr; TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt 0.5in; TEXT-INDENT: -27pt; mso-list: l0 level1 lfo1"><FONT size=2 face="Times New Roman"><SPAN style='mso-bidi-font-family: "Times New Roman"'>26. </SPAN></FONT><SPAN class=messageheaderlabel><B><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman","serif"; mso-bidi-language: AR-SA; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-US; mso-fareast-language: EN-US'>Mustafa AS</SPAN></B><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman","serif"; mso-bidi-language: AR-SA; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-US; mso-fareast-language: EN-US'>, Shaban F (2010). Mapping of Th1-cell epitope regions of <I>Mycobacterium tuberculosis</I> protein MPT64 (</SPAN></SPAN><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman","serif"; mso-bidi-language: AR-SA; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-US; mso-fareast-language: EN-US'>Rv1980c)<SPAN class=messageheaderlabel> using synthetic peptides and T-cell lines from <I>M. tuberculosis</I>-infected healthy humans</SPAN>. <B style="mso-bidi-font-weight: normal">Medical Principles and Practice</B><SPAN style="mso-bidi-font-weight: bold"> 19:122-128.</SPAN><SPAN class=messageheaderlabel> </SPAN></SPAN></P></SPAN>
Copyright © 1993 - 2021
Health Sciences Center - All Rights Reserved.